Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Adaptive Biotechnologies Corp
(NQ:
ADPT
)
4.690
+0.320 (+7.32%)
Streaming Delayed Price
Updated: 4:00 PM EST, Nov 22, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Adaptive Biotechnologies Corp
< Previous
1
2
3
4
5
6
Next >
Adaptive Biotechnologies to Hold a Business Update Conference Call and Webcast on April 2, 2024
March 27, 2024
From
Adaptive Biotechnologies
Via
GlobeNewswire
Adaptive Biotechnologies to Present at the TD Cowen 44th Annual Healthcare Conference
February 22, 2024
From
Adaptive Biotechnologies
Via
GlobeNewswire
12 Health Care Stocks Moving In Thursday's Pre-Market Session
February 15, 2024
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
February 14, 2024
Via
Benzinga
Adaptive Biotechnologies: Q4 Earnings Insights
February 14, 2024
Via
Benzinga
Earnings Scheduled For February 14, 2024
February 14, 2024
Companies Reporting Before The Bell • Sony Group (NYSE:SONY) is projected to report quarterly earnings at $1.65 per share on revenue of $24.62 billion.
Via
Benzinga
Earnings Preview For Adaptive Biotechnologies
February 13, 2024
Via
Benzinga
Adaptive Biotechnologies Reports Fourth Quarter and Full Year 2023 Financial Results
February 14, 2024
From
Adaptive Biotechnologies
Via
GlobeNewswire
Adaptive Biotechnologies to Report Fourth Quarter and Full Year 2023 Financial Results on February 14, 2024
January 29, 2024
From
Adaptive Biotechnologies
Via
GlobeNewswire
Adaptive Biotechnologies to Present at the 42nd Annual J.P. Morgan Healthcare Conference
December 27, 2023
From
Adaptive Biotechnologies
Via
GlobeNewswire
Recap: Adaptive Biotechnologies Q3 Earnings
November 09, 2023
Via
Benzinga
Adaptive Biotechnologies's Earnings Outlook
November 08, 2023
Via
Benzinga
Expert Ratings for Adaptive Biotechnologies
October 24, 2023
Via
Benzinga
Cathie Wood's Ark Invest Sells Nearly $11.5M Worth Of Coinbase Shares As Bitcoin, Crypto Rally Loses Steam
December 12, 2023
Via
Benzinga
Cathie Wood Is Loading Up on These 3 Small-Cap Stocks: Should You?
December 12, 2023
The Ark Invest founder sees potential in these three under-the-radar stocks.
Via
The Motley Fool
Cathie Wood's Ark Dumps $12.8M Worth Of Grayscale Bitcoin Trust Amid Crypto Rally Losing Wind In Sails
December 11, 2023
On Monday, Cathie Wood-led Ark Invest made a significant move by selling over $12.8 million worth of Grayscale Bitcoin Trust (OTC:GBTC) shares, amidst fluctuating cryptocurrency prices.
Via
Benzinga
Adaptive Biotechnologies Announces New Data Highlighting the Clinical Relevance of MRD Testing with clonoSEQ® in Patients with Blood Cancers at the 65th ASH Annual Meeting
December 09, 2023
From
Adaptive Biotechnologies
Via
GlobeNewswire
Cathie Wood's Ark Invest Trims Bitcoin Exposure, Sells $2.9M Worth Of GBTC Shares Amid Crypto Market Volatility
December 07, 2023
On Thursday, Cathie Wood-led Ark Invest made a significant move by selling nearly $2.9 million worth of Grayscale Bitcoin Trust (OTC:GBTC) shares. This decision comes amidst a fluctuating crypto market...
Via
Benzinga
Adaptive Biotechnologies and Collaborators to Present More than 30 Abstracts Demonstrating the Actionability of clonoSEQ® MRD Testing in Blood Cancer Patient Care and Drug Development at the 65th ASH Annual Meeting
December 05, 2023
From
Adaptive Biotechnologies
Via
GlobeNewswire
Azenta Reports Upbeat Earnings, Joins Talis Biomedical, Sally Beauty And Other Big Stocks Moving Higher On Tuesday
November 14, 2023
U.S. stocks traded higher, with the Dow Jones gaining around 500 points on Tuesday. Shares of Azenta, Inc. (NASDAQ: AZTA) rose on Tuesday after the company reported better-than-expected fourth-quarter...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why Beyond Air Shares Are Trading Lower By Around 37%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
November 14, 2023
Shares of Beyond Air, Inc. (NASDAQ: XAIR) dipped during Tuesday’s session following weak quarterly results.
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
November 10, 2023
Via
Benzinga
Why Wynn Resorts Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Friday's Mid-Day Session
November 10, 2023
Shares of Wynn Resorts, Limited (NASDAQ: WYNN) fell sharply on Friday after the company reported third-quarter financial results.
Via
Benzinga
Adaptive Biotechnologies Reports Third Quarter 2023 Financial Results and Provides Business Update
November 09, 2023
From
Adaptive Biotechnologies
Via
GlobeNewswire
Adaptive Biotechnologies Announces New Translational Collaboration to Measure Minimal Residual Disease with clonoSEQ® Assay Across BeiGene’s Lymphoid Malignancy Pipeline
November 07, 2023
From
Adaptive Biotechnologies
Via
GlobeNewswire
Adaptive Biotechnologies to Report Third Quarter Financial Results on November 9, 2023
November 02, 2023
From
Adaptive Biotechnologies
Via
GlobeNewswire
Why TD SYNNEX Shares Are Trading Lower By Over 5%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
September 26, 2023
Gainers Soleno Therapeutics, Inc. (NASDAQ: SLNO) shares jumped 318.5% to $18.54 after the company released top-line results from randomized withdrawal period of study C602 of DCCR for Prader-Willi...
Via
Benzinga
What's Going On With Adaptive Biotechnologies (ADPT) Stock?
September 26, 2023
Adaptive Biotechnologies Corporation (NASDAQ: ADPT) shares are trading higher Tuesday despite a lack of company-specific news.
Via
Benzinga
Fisker, Intercept Pharmaceuticals, Immunovant And Other Big Stocks Moving Higher On Tuesday
September 26, 2023
U.S. stocks traded lower, with the Dow Jones falling around 200 points on Tuesday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why Femasys Shares Are Trading Higher By Over 200%; Here Are 20 Stocks Moving Premarket
September 26, 2023
Gainers Femasys Inc. (NASDAQ: FEMY) shares rose 201% to $1.00 in pre-market trading after the company received FDA 510(k) clearance for FemaSeed, an infertility treatment.
Via
Benzinga
Exposures
Product Safety
< Previous
1
2
3
4
5
6
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.